Alpha‐Klotho, a critical protein for lung health, is not expressed in normal lung
Autor: | Connie C.W. Hsia, Khoa Cao, Jianning Zhang, Liping Li, Johanne Pastor, Orson W. Moe |
---|---|
Rok vydání: | 2019 |
Předmět: |
Cancer Research
Pathology medicine.medical_specialty mice Physiology medicine.drug_class Lung injury Monoclonal antibody Biochemistry Genetics and Molecular Biology (miscellaneous) inhalational cDNA delivery 03 medical and health sciences 0302 clinical medicine immunoblot medicine human lcsh:QH301-705.5 Research Articles 030304 developmental biology 0303 health sciences Kidney Lung biology business.industry 3. Good health medicine.anatomical_structure lcsh:Biology (General) Apoptosis 030220 oncology & carcinogenesis immunohistochemistry Monoclonal biology.protein Molecular Medicine Immunohistochemistry monoclonal antibodies Erratum Antibody business Research Article |
Zdroj: | FASEB BioAdvances FASEB BioAdvances, Vol 1, Iss 11, Pp 675-687 (2019) FASEB bioAdvances |
ISSN: | 2573-9832 |
DOI: | 10.1096/fba.2019-00016 |
Popis: | Alpha‐Klotho (αKlotho), produced by the kidney and selected organs, is essential for tissue maintenance and protection. Homozygous αKlotho‐deficiency leads to premature multi‐organ degeneration and death; heterozygous insufficiency leads to apoptosis, oxidative stress, and increased injury susceptibility. There is inconsistent data in the literature regarding whether αKlotho is produced locally in the lung or derived from circulation. We probed murine and human lung by immunohistochemistry (IHC) and immunoblot (IB) using two monoclonal (anti‐αKlotho Kl1 and Kl2 domains) and three other common commercial antibodies. Monoclonal anti‐Kl1 and anti‐Kl2 yielded no labeling in lung on IHC or IB; specific labeling was observed in kidney (positive control) and also murine lungs following tracheal delivery of αKlotho cDNA, demonstrating specificity and ability to detect artificial pulmonary expression. Other commercial antibodies labeled numerous lung structures (IHC) and multiple bands (IB) incompatible with known αKlotho mobility; labeling was not abolished by blocking with purified αKlotho or using lungs from hypomorphic αKlotho‐deficient mice, indicating nonspecificity. Results highlight the need for rigorous validation of reagents. The lung lacks native αKlotho expression and derives full‐length αKlotho from circulation; findings could explain susceptibility to lung injury in extrapulmonary pathology associated with reduced circulating αKlotho levels, for example, renal failure. Conversely, αKlotho may be artificially expressed in the lung, suggesting therapeutic opportunities. |
Databáze: | OpenAIRE |
Externí odkaz: |